OSAIC HOLDINGS, INC. - NEOLEUKIN THERAPEUTICS INC ownership

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of NEOLEUKIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$1,245
+15.3%
1,5000.0%0.00%
Q1 2023$1,080
+8.0%
1,5000.0%0.00%
Q4 2022$1,0000.0%1,5000.0%0.00%
Q3 2022$1,000
-50.0%
1,500
-33.7%
0.00%
Q2 2022$2,000
-99.9%
2,264
+50.9%
0.00%
-100.0%
Q1 2022$3,390,000
+48328.6%
1,5000.0%0.01%
Q4 2021$7,000
-36.4%
1,5000.0%0.00%
Q3 2021$11,000
+10.0%
1,500
+50.0%
0.00%
Q2 2021$10,000
-23.1%
1,0000.0%0.00%
Q1 2021$13,000
-23.5%
1,000
-16.7%
0.00%
Q4 2020$17,0001,2000.00%
Other shareholders
NEOLEUKIN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,386,300$19,547,0002.55%
EcoR1 Capital, LLC 3,122,704$44,030,0002.37%
Redmile Group, LLC 4,131,869$58,259,0000.70%
Boxer Capital, LLC 1,501,058$21,165,0000.68%
HighVista Strategies LLC 69,727$983,0000.63%
Baker Brothers Advisors 3,821,740$53,887,0000.20%
Highland Private Wealth Management 93,998$1,326,0000.12%
Sio Capital Management, LLC 38,312$540,0000.11%
Point72 Asset Management, L.P. 1,195,725$16,860,0000.08%
Granahan Investment Management 246,299$3,473,0000.08%
View complete list of NEOLEUKIN THERAPEUTICS INC shareholders